dihexa hgf/c-met potentiator HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers Targeting cancer-associated fibroblast-activated HGF/c-MET pathway

Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic DIHEXA Activated HGF c Met Axis in Head and Neck Cancer

SKU: 9933087528 · From eiffelbuilders.com